Search results
Eli Lilly wants to replace Zepbound with an even stronger weight loss drug
Quartz· 3 days agoSkyrocketing sales of tirzepatide — the active ingredient in Mounjaro and Zepbound — transformed Eli...
Food companies worried about weight loss drugs can just make healthier food, Eli Lilly CEO says
Quartz· 3 days agoDavid Ricks, the CEO of Mounjaro and Zepbound maker Eli Lilly, says that food, diet, and fitness...
Eli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
Yahoo Finance via AOL· 7 days agoEli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound —...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 3 days agoThe next step was a larger, expensive clinical study. Looking...
Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple
Investor's Business Daily· 5 days agoRevenue from Eli Lilly's weight-loss drug is expected to triple over the next five years to over ...
Michigan’s largest insurer to drop weight-loss drug coverage
Chicago Tribune· 5 days agoWeight-loss drugs from Novo Nordisk A/S and Eli Lilly & Co. will lose coverage under many plans run...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 6 days agoAfter a year, more than half of patients who received Lilly's mirikizumab entered remission. And...
Eli Lilly Stock Reaches All-Time High: What’s Driving It Higher? | Bankrate
Bankrate.com· 5 days agoHere’s a quick recap of how Eli Lilly got here and what investors might expect moving forward. The ...
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
Motley Fool via Yahoo Finance· 2 days agoEli Lilly also has exciting pipeline candidates like efsitora alfa, a potential once-weekly insulin...
Is Eli Lilly the Best Pharmaceutical Stock for You? | The Motley Fool
The Motley Fool· 5 days agoEli Lilly (LLY -0.55%) stock has soared 90% over the past year, a huge gain for a pharmaceutical...